Phloroglucinol, isolated from the brown alga E. cava, diminished the population of breast cancer cell lines (MCF7, SKBR3 and BT549) in tumors, by inhibiting KRAS and its downstream PI3K/Akt and RAF-1/ERK signaling pathways. The gene discussed is KRAS; the disease is breast carcinoma.